If you are an Aetna member and received a letter regarding contract negotiations with NewYork-Presbyterian, you may find out the latest information here.

Locations and Appointments

Insurances Accepted

For relevant information regarding accepted insurances, please contact this provider directly.

Biographical Info

Dr. Doruk Erkan is an Associate Physician-Scientist at the Barbara Volcker Center for Women and Rheumatic Diseases, Associate Attending Rheumatologist and Clinical Researcher at Hospital for Special Surgery, and Associate Professor of Medicine at Weill Cornell Medical College.

In addition to his rheumatology practice, Dr. Erkan has a long-standing research interest in Antiphospholipid Syndrome (an autoimmune clotting disorder) and Systemic Lupus Erythematosus (SLE or “lupus”). After his Internal Medicine residency at Beth Israel Medical Center in New York, he completed his Rheumatology fellowship at Hospital for Special Surgery in New York. Dr. Erkan has a medical doctor (MD) degree from Hacettepe University School of Medicine in Ankara, Turkey and a master of public health (MPH) degree from Johns Hopkins University School of Public Health in Baltimore, Maryland.

Dr. Erkan has received several honors and awards from the American College of Rheumatology and the Arthritis Foundation for his research. He has published over 200 articles including research papers and invited editorials, as well as over 35 book chapters, and he has given over 170 research presentations and 200 invited lectures. He is the co-editor of two Antiphospholipid Syndrome textbooks and the Neurology volume of the Handbook of Systemic Autoimmune Disease. Dr. Erkan is also the Associate Editor of Hospital for Special Surgery’s Manual of Rheumatology and Outpatient Orthopedic Disorders.

Honors and Awards

• Castle Connolly Top Doctors in New York Metro Area, 2016-2021

• New York Magazine Top Doctors, 2021

• Castle Connolly Regional Top Doctor, 2015-2020

• R13 Antiphospholipid Syndrome Conference Grant, National Heart, Lung, Blood Institute, NIH, 2016

• ACR/EULAR Exchange Program Participant, 2015

• HSS Academy of Rheumatology Medical Educator Award, 2015

• Antiphospholipid Syndrome Research Award, New York Community Trust, 2012

• Clinical & Translational Science Center Pilot Award, Cornell Medical College, 2011

• Lupus Research Award, New York Community Trust, 2008

• Rudd-Gardy Teaching Excellence Award, HSS Division of Rheumatology, 2008

• Young Investigator Award, AESKU.KIPP Institute, Germany, 2007

• Young Investigator Initiative Award, US Bone and Joint Decade, 2006

• Antiphospholipid Syndrome Research Award, New York Community Trust, 2004

• Dorothy W. Goldstein Young Scholar Award, Arthritis Foundation, New York Chapter, 2002

• Rheumatology Fellow Award, American College of Rheumatology, 2001

• Postdoctoral Fellowship Award, Arthritis Foundation, New York Chapter, 2001

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Rheumatology)
Clinical Expertise
Antiphospholipid Syndrome (APS) In Pregnancy
Systemic Lupus Erythematosus (SLE) In Pregnancy
APL (Antiphospholipid Syndrome)
Systemic Lupus Erythematosus
Medical Multimedia For Physician and Patient Education
APS (Antiphospholipid Syndrome)
  • M.P.H.
    The Johns Hopkins University Bloomberg School of Public Health
  • M.D.
    Hacettepe University Faculty of Medicine (Turkey)
  • Attending Physician
    Hospital for Special Surgery
  • Attending Physician
    NewYork-Presbyterian Hospital
  • Professor of Medicine
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

American College of Rheumatology
Celgene Corporation
Momenta Pharmaceuticals, Inc.
Other Interest: